PledPharma has an innovative, unique and integrated competence in pharmaceutical drug development with focus on improving treatments for severe diseases with substantial unmet medical need where alternative treatments do not exist.

Latest Report

November 11, 2020

Latest interim report

Latest presentation

Calendar and upcoming reports

November 11, 2020

Interim report third quarter 2020

November 9-23, 2020

Subscription period rights issue

November 9-12, 2020

Trading in subscription rights

December 11, 2020

Extra General Meeting

February 17, 2021

Year end report

Share

Twitter
LinkedIn

Contact us

Address: Grev Turegatan 11 C, 114 46 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@pledpharma.com